Skip to main content
Advertisement
Live broadcast

Scientists have discovered a link between immune proteins and prostate cancer risk

Nature Communications: Immune proteins linked to prostate cancer risk
0
Photo: RIA Novosti/Ilya Pitalev
Озвучить текст
Select important
On
Off

The immune system helps the body recognize and control abnormal cells, but its role in the earliest stages of cancer development is not fully understood. Researchers have found that the level of certain immune proteins is associated with the likelihood of developing prostate cancer, and differences can be noticed many years before diagnosis. The information about which molecules were associated with the risk of the disease and what this discovery says about the role of immunity is in the Izvestia material.

Immune proteins were studied years before the diagnosis

The work of researchers at the Oxford Center for Population Health has been published in the journal Nature Communications. Scientists studied 368 proteins involved in immune and inflammatory processes, and compared their concentration in the blood with the subsequent risk of prostate cancer.

The researchers compared blood samples from 1,434 men who were subsequently diagnosed with prostate cancer, and 1,434 men without such a diagnosis. On average, more than 10 years passed between blood collection and the detection of the disease. Additionally, the researchers analyzed data from 21,481 participants, including 1,147 cases of prostate cancer.

This approach allowed us to assess whether the features of the immune system are associated with the likelihood of developing a tumor long before it is detected. In addition, the scientists used genetic methods to check whether the identified links could indicate a possible causal effect of individual proteins.

Interleukin-15 has been linked to a lower risk of disease

One of the most notable results was the association with interleukin-15 (IL-15), a protein that helps support the work of T cells and natural killer cells, or NK cells. These elements of the immune system are involved in the recognition and destruction of abnormal cells.

In the combined analysis, a higher concentration of IL-15 was associated with a 14% lower risk of prostate cancer if diagnosed more than seven years after taking a blood sample. In the European group, scientists also found a link between increased levels of this protein and the likelihood of developing more aggressive forms of the disease: the risk was 26% lower.

Similar patterns were found for several other immune proteins — FLT3LG, BCL2L11, PGF, CKAP4, and TNFRSF11A. Their higher concentration was also associated with a lower chance of developing prostate cancer seven or more years after the blood test.

Mahbube Parsaian, Head of the study

Prostate cancer has traditionally been considered an immunologically "cold" tumor — it was assumed that it does not cause a strong immune response and prevents the body from using its own defense mechanisms to destroy tumor cells. However, we usually study the immune system after the appearance of the tumor. Our results show that it may play a role in the early stages of prostate cancer development or suppression.

The PARP1 protein showed the opposite relationship

The researchers paid special attention to PARP1, a protein that is involved in repairing damaged DNA. Unlike IL-15, a genetic predisposition to higher concentrations of PARP1 was associated with an increased risk of prostate cancer.

This pattern was confirmed by an independent multi-ethnic sample. The use of genetic data is important for interpreting the results: this approach helps to assess whether a change in protein levels can be associated with the development of the disease, and not just accompany existing processes.

However, these data do not mean that an increased concentration of PARP1 causes cancer by itself. Genetic methods allow us to investigate possible causal mechanisms, but they do not provide a definitive answer about how exactly the protein is involved in the formation of a tumor.

Carl Smith-Byrne, senior author of the study

It is particularly noteworthy that the most pronounced immune signals were present more than seven years before the diagnosis. This indicates a much earlier period when the immune system can help control abnormal cells.

How can immunity affect the development of a tumor

The results suggest that the immune system is involved in the processes that determine whether abnormal cells can continue to develop and form a tumor. In particular, IL-15 supports the activity of cells capable of recognizing and destroying potentially dangerous cells. Therefore, the association of its higher concentration with a lower risk of disease is of particular interest for further study.

At the same time, scientists have not yet established how all the discovered proteins interact with each other and what mechanisms underlie the revealed patterns. Observational data show a link between the concentration of molecules and the subsequent risk of disease, but by themselves do not prove that changing the level of a particular protein prevents the development of a tumor.

The next step will be to study the interaction of these proteins and the biological processes in which they are involved. The researchers hope to better understand which mechanisms of the immune system are involved in the control of abnormal cells and at which stages of disease development they are most important.

Thus, the work shows that the features of the immune response may be associated with the risk of prostate cancer long before the appearance of clinical signs. However, the discovered proteins cannot yet be used as a ready-made tool for individual prognosis: this requires additional research and verification of the results in other groups of people.

Переведено сервисом «Яндекс Переводчик»

Live broadcast